Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2009-10-30FDA Approved: LIALDA — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approves a supplemental application for LIALDA (mesalamine) submitted by Takeda Pharmaceuticals America, Inc.
-
CLINICAL_TRIALS trial_result · 2009-10-21Clinical Trial Update: An Assessment of Goal-Directed Intraoperative Fluid Management in Hand Assisted Laparoscopic Colectomy [Phase 3]
A Phase 3 trial assessing goal-directed intraoperative fluid management during hand-assisted laparoscopic colectomy has completed; the snipp…
-
FDA approval · 2009-10-19FDA Approved: AZULFIDINE EN-TABS — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for Azulfidine EN-Tabs (sulfasalazine) from Pfizer Laboratories Div Pfizer Inc.
-
CLINICAL_TRIALS research · 2009-10-14Clinical Trial Update: Assessment of Colonic Permeability by Confocal Laser Endomicroscopy
This clinical trial is evaluating colonic permeability in inflammatory bowel disease and ulcerative colitis using confocal laser endomicrosc…
-
CLINICAL_TRIALS trial_result · 2009-09-10Clinical Trial Update: A Phase 2a Study to Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of AG011 in Ulcerative Colitis [Phase 1, Phase 2]
Clinical trial update for AG011 in ulcerative colitis, reporting completion of Phase 1/Phase 2a evaluation of safety, tolerability, pharmaco…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-08-05FDA Approved: DIPENTUM — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Dipentum (olsalazine sodium) submitted by Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2009-08-04Clinical Trial Update: Food Supplementation With VSL#3 as a Support to Standard Pharmaceutical Therapy in Ulcerative Colitis [NA]
The trial evaluating the probiotic VSL#3 as an adjunct to standard therapy for ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2009-07-20Clinical Trial Update: Humanized Anti-IL-2 Receptor Monoclonal Antibody in Moderate-to-severe Ulcerative Colitis [Phase 2]
Clinical trial update on a Phase 2 study of a humanized anti-IL-2 receptor monoclonal antibody for moderate-to-severe ulcerative colitis. Th…
-
CLINICAL_TRIALS trial_result · 2009-06-26Clinical Trial Update: A Study To Investigate The Safety And Efficacy Properties Of PF-00547659 In Patients With Active Ulcerative Colitis [Phase 1]
A Phase 1 trial evaluated the safety and preliminary efficacy of PF-00547659 in patients with active ulcerative colitis and the study has co…
-
CLINICAL_TRIALS withdrawal · 2009-06-25Clinical Trial Update: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis [Phase 3]
A Phase 3 trial evaluating visilizumab for intravenous steroid-refractory ulcerative colitis was withdrawn.
-
CLINICAL_TRIALS trial_result · 2009-05-18Clinical Trial Update: GI-270384 Study In Patients With Mild To Moderate Ulcerative Colitis [Phase 1]
Phase 1 study GI-270384 in mild-to-moderate ulcerative colitis sponsored by GlaxoSmithKline has been terminated.
-
CLINICAL_TRIALS trial_result · 2009-04-28Clinical Trial Update: Therapeutic Study of ONO-4819CD for Ulcerative Colitis [Phase 2]
Phase 2 study of ONO-4819CD for Ulcerative Colitis has been terminated.
-
CLINICAL_TRIALS trial_result · 2009-04-28Clinical Trial Update: CESA 5.10 Investigation to Compare the Efficacy and Safety of the Adacolumn® Apheresis Device in Patients With Active Ulcerative Colitis [NA]
A completed clinical trial evaluating the efficacy and safety of the Adacolumn apheresis device in patients with active ulcerative colitis. …
-
FDA approval · 2009-04-24FDA Approved: SIMPONI — Original Application (Janssen Biotech, Inc.)
FDA approved the original Biologics License Application for Simponi (golimumab) from Janssen Biotech, Inc.
-
CLINICAL_TRIALS trial_result · 2009-03-25Clinical Trial Update: Efficacy and Tolerability of a New Oral Extended-Release Formulation Containing Parnaparin Sodium, Administered Add-on Therapy [Phase 2]
Phase 2 trial evaluating efficacy and tolerability of an oral extended-release parnaparin sodium formulation as add-on therapy in Ulcerative…
-
CLINICAL_TRIALS trial_result · 2009-03-17Clinical Trial Update: Effect of Iron and Vitamin E Supplementation on Disease Activity in Patients With Either Crohn's Disease or Ulcerative Colitis [Phase 2]
Phase 2 trial evaluating iron and vitamin E supplementation for disease activity in Crohn's disease and ulcerative colitis was terminated.
-
CLINICAL_TRIALS trial_result · 2009-02-16Clinical Trial Update: Amount of Lactose Causing Symptoms in People With Lactose Intolerance and Ulcerative Colitis
A completed clinical trial investigated the amount of lactose that triggers symptoms in people with lactose intolerance and ulcerative colit…
-
CLINICAL_TRIALS trial_result · 2009-02-16Clinical Trial Update: Methods of Improvement Adherence With Therapy in Ulcerative Colitis. [Phase 3]
Phase 3 clinical trial update focused on methods to improve adherence to therapy in Ulcerative Colitis.
-
CLINICAL_TRIALS trial_result · 2009-02-11Clinical Trial Update: Antibiotics for the Treatment of Ulcerative Colitis [NA]
The clinical trial NCT00355602, sponsored by the University of Dundee, investigating antibiotics for the treatment of ulcerative colitis has…
-
CLINICAL_TRIALS trial_result · 2009-01-30Clinical Trial Update: Metabolic Response to Infliximab in Pediatric Ulcerative Colitis [NA]
A pediatric ulcerative colitis trial assessing metabolic response to infliximab was terminated.
-
CLINICAL_TRIALS trial_result · 2009-01-27Clinical Trial Update: Pneumococcal Vaccination in Patients With Inflammatory Bowel Disease [NA]
A completed clinical trial evaluating pneumococcal vaccination in patients with inflammatory bowel disease, including Crohn's disease and Ul…
-
CLINICAL_TRIALS trial_result · 2008-12-18Clinical Trial Update: Basiliximab in Moderate to Severe Ulcerative Colitis [Phase 2]
Phase 2 trial evaluating Basiliximab for moderate to severe ulcerative colitis has completed (sponsor Cerimon Pharmaceuticals).
-
CLINICAL_TRIALS trial_result · 2008-12-10Clinical Trial Update: Nolpitantium Besylate In Patients With Ulcerative Colitis a Double-Blind, Placebo Controlled Efficacy and Safety Study [Phase 2]
A Phase 2 double-blind, placebo-controlled trial evaluating Nolpitantium Besylate for efficacy and safety in ulcerative colitis has been com…
-
CLINICAL_TRIALS research · 2008-12-09Clinical Trial Update: Importance of CD4+CD25+ly in UC1. Investigation of Difference Between Blood Concentration IL 17, IL 33, Regulatory T ly in Patients With UC and Control Group
This trial update investigates differences in blood concentrations of IL-17, IL-33, and regulatory T cells in patients with ulcerative colit…
-
CLINICAL_TRIALS trial_result · 2008-11-19Clinical Trial Update: The Efficacy and Tolerability of Coltect as Add-on in Patients With Active Ulcerative Colitis - an Open Label [NA]
Open-label trial assessing the efficacy and tolerability of Coltect as add-on therapy in patients with active ulcerative colitis.